









Markets
/
Stocks
/
nasdaq-zvsa
/

Zyversa Therapeutics Inc

ZVSA

0.311USD

0.000

Close 09/19, 16:00（ET）Quotes delayed by 15 min

799.48KMarket Cap

LossP/E TTM



Zyversa Therapeutics Inc

0.311

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

Operating expenses

-24.13%2.14M

-27.57%1.29M

-21.81%2.27M

-46.52%2.75M

-38.45%2.83M

-65.75%1.78M

-14.51%2.90M

173.43%5.15M

36.33%4.59M

191.92%5.19M

60.57%3.40M

1.77%1.88M

71.61%3.37M

--1.78M

--2.11M

--1.85M

--1.96M

R&D expenses

-49.53%258.88K

-52.84%121.25K

-35.30%436.04K

-41.91%709.05K

-51.42%512.94K

-84.76%257.11K

-71.13%673.94K

69.67%1.22M

-1.03%1.06M

166.15%1.69M

473.57%2.33M

44.89%719.39K

81.81%1.07M

--633.97K

--406.95K

--496.51K

--586.85K

Depreciation, depletion, and amortization

-100.00%0.00

-33.35%1.73K

0.00%2.60K

--2.60K

Operating profit

24.13%-2.14M

27.57%-1.29M

21.81%-2.27M

46.52%-2.75M

38.45%-2.83M

65.75%-1.78M

14.51%-2.90M

-173.43%-5.15M

-36.33%-4.59M

-191.92%-5.19M

-60.57%-3.40M

-1.77%-1.88M

-71.61%-3.37M

---1.78M

---2.11M

---1.85M

---1.96M

Net non-operating interest income (expenses)

Non-operating interest expense

----

-75.71%49.72K

-69.24%69.35K

-36.57%140.40K

-1.03%168.06K

--204.72K

--225.49K

--221.34K

--169.82K

Special income (expenses)

--7.20K

----

-6422.63%-12.16M

100.00%0.00

-414259.20%-81.18M

----

-1627.88%-186.40K

-149.59%-228.10K

184.85%19.60K

-2725.36%-212.10K

--12.20K

--459.99K

---23.10K

---7.51K

Income before tax

20.16%-2.26M

89.78%-1.42M

17.28%-2.40M

96.81%-2.75M

38.43%-2.83M

-156.98%-13.93M

21.39%-2.90M

-4207.19%-86.33M

-22.48%-4.59M

-175.37%-5.42M

-96.43%-3.69M

4.34%-2.00M

-75.15%-3.75M

---1.97M

---1.88M

---2.10M

---2.14M

Income tax

----

99.50%-2.96K

100.00%0.00

100.12%9.71K

100.00%0.00

20.00%-596.07K

---485.00

---7.81M

---1.05M

---745.05K

----

Income after tax

20.16%-2.26M

89.34%-1.42M

17.27%-2.40M

96.48%-2.76M

20.24%-2.83M

-185.18%-13.34M

21.40%-2.90M

-3817.40%-78.51M

5.46%-3.54M

-137.53%-4.68M

-96.43%-3.69M

4.34%-2.00M

-75.15%-3.75M

---1.97M

---1.88M

---2.10M

---2.14M

Net income from continuous operations

20.16%-2.26M

89.34%-1.42M

17.27%-2.40M

96.48%-2.76M

20.24%-2.83M

-185.18%-13.34M

21.40%-2.90M

-3817.40%-78.51M

5.46%-3.54M

-137.53%-4.68M

-96.43%-3.69M

4.34%-2.00M

-75.15%-3.75M

---1.97M

---1.88M

---2.10M

---2.14M

Net income attributable to controlling interests

20.16%-2.26M

89.34%-1.42M

18.18%-2.40M

96.80%-2.76M

20.24%-2.83M

-185.18%-13.34M

78.06%-2.93M

-3600.80%-86.43M

5.46%-3.54M

-137.53%-4.68M

-611.59%-13.38M

-11.47%-2.34M

-75.15%-3.75M

---1.97M

---1.88M

---2.10M

---2.14M

Preferred share dividend

----

--0.00

-99.67%32.37K

2290.05%7.92M

----

--0.00

--9.68M

--331.20K

----

--0.00

----

Net income attributable to common shareholders

20.16%-2.26M

89.34%-1.42M

18.18%-2.40M

96.80%-2.76M

20.24%-2.83M

-185.18%-13.34M

78.06%-2.93M

-3600.80%-86.43M

5.46%-3.54M

-137.53%-4.68M

-611.59%-13.38M

-11.47%-2.34M

-75.15%-3.75M

---1.97M

---1.88M

---2.10M

---2.14M

Basic earnings per share

83.97%-0.73

98.80%-0.71

92.67%-2.43

99.80%-3.31

96.66%-4.53

66.45%-59.63

93.48%-33.16

-1809.27%-1.69K

4.59%-135.88

-137.53%-177.71

-611.60%-508.26

-11.47%-88.73

-75.15%-142.42

---74.82

---71.42

---79.60

---81.31

Diluted earnings per share

83.97%-0.73

98.80%-0.71

92.67%-2.43

99.80%-3.31

96.66%-4.53

66.45%-59.63

93.48%-33.16

-1809.27%-1.69K

4.59%-135.88

-137.53%-177.71

-611.60%-508.26

-11.47%-88.73

-75.15%-142.42

---74.82

---71.42

---79.60

---81.31

Dividend per share

--0.00

Currency unit

USD

Audit opinions

KeyAI

